Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2014 · 10-Q
Revenue$69.02M$69.02M−20.2% vs Q3 2013 Net Income$4.86M$4.86M−14.4% vs Q3 2013 EPS Diluted$0.39$0.39−4.9% vs Q3 2013 Gross Profit$50,734,000−21.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,263,000+29.6% Free Cash Flowderived$7,074,000+113.8% Margins · derivedGross margin73.5%−1.5 pt vs Q3 2013
Operating margin9.5%+1.1 pt vs Q3 2013
Net margin7.0%+0.5 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 10, 2014 · 41 d after period end